[D23-01] Biomarkers in primary breast cancer
Last updated 18.11.2024
Project no.:
D23-01
Commission:
Commission awarded on 12.05.2023 by the Federal Joint Committee (G-BA).
Report type:
Report
Status:
Commission completed
Department/Division:
Non-Drug Interventions
Topic:
Cancer, Diagnostics
Note:
Both commissions are processed in a joint report.
- D23-01A: Biomarker-based tests for deciding for or against adjuvant systemic chemotherapy in primary breast cancer with involvement of 1-3 lymph nodes- Awarded by the Federal Joint Committee (G-BA) on 12 May 2023.
- D23-01B - Biomarker-based tests for deciding for or against adjuvant systemic chemotherapy in premenopausal women with primary breast cancer without lymph node involvement - Awarded by the Federal Joint Committee (G-BA) on 21 September 2023.
DOI:
https://doi.org/10.60584/D23-01B